Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study
Tatsuya Ide(Kurume University), Takuji Torimura(Omuta hospital), Masahito Nakano(Kurume University), Seiichi Mawatari(Kagoshima University), Hironori Koga(Kurume University), Tatsuji Maeshiro(University of the Ryukyus University Hospital), Yuichi Honma(University of Occupational and Environmental Health Japan), Kazuhiko Nakao(Nagasaki University), Satoshi Oeda(Saga Medical School Hospital), Masataka Seike(Oita University), Kenji Nagata, Yuichiro Eguchi(Saga University), Hiroshi Yatsuhashi(Nagasaki Medical Center), Tetsuo Sohda(Japanese Red Cross Fukuoka Hospital), Nobito Higuchi, Yutaka Sasaki(The University of Osaka), Satoshi Miuma(University of Nagasaki), Masaru Harada(University of Occupational and Environmental Health Japan), Yuko Takami(National Kyushu Medical Center), Satoshi Shakado(Fukuoka University), Yoko Yoshimaru(Kumamoto University), Tatsuyuki Kakuma(Kurume University), Shotaro Sakisaka(Fukuoka University), Shuichi Matsumoto(Fukuoka Tokushukai Hospital), Makoto Nakamuta(Nagasaki Medical Center), Akio Ido(Kagoshima University), Satoru Hashimoto(Nagasaki Medical Center)
Cited by 56
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410